The Histone Deacetylase Inhibitor Sodium Butyrate Interacts Synergistically with Phorbol Myristate Acetate (PMA) to Induce Mitochondrial Damage and Apoptosis in Human Myeloid Leukemia Cells through a Tumor Necrosis Factor-α-Mediated Process

This publication has 49 references indexed in Scilit:

• Maturation Versus Death of Developing Double-Positive Thymocytes Reflects Competing Effects on Bcl-2 Expression and Can Be Regulated by the Intensity of CD28 Costimulation
  The Journal of Immunology, 2001
• Up-regulation of costimulatory/adhesion molecules by histone deacetylase inhibitors in acute myeloid leukemia cells
  Blood, 2000
• Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
  JNCI Journal of the National Cancer Institute, 2000
• Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways
  Blood, 2000
• Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53
  Oncogene, 1999
• Depsipeptide (FR901228): A Novel Therapeutic Agent With Selective, In Vitro Activity Against Human B-Cell Chronic Lymphocytic Leukemia Cells
  Blood, 1999
• Sustained activation of protein kinase C is essential to HL-60 cell differentiation to macrophage.
  Proceedings of the National Academy of Sciences, 1991
• Temporal changes in intracellular distribution of protein kinase C during differentiation of human leukemia HL60 cells induced by phorbol ester
  FEBS Letters, 1988
• Clinical pharmacology of sodium butyrate in patients with acute leukemia
  European Journal of Cancer and Clinical Oncology, 1987
• The control of phospholipid methylation by phorbol diesters in differentiating human myeloid HL-60 leukemia cells
  Carcinogenesis: Integrative Cancer Research, 1982